Achieve great success, and blaze a trail: Review of clinical and basic research progress of Chinese diabetes in the 21st century

Chinese Medical Journal

Volumn 122, Issue 21, 2009, Pages 2525-2529

  Yang, Wen Ying ^a  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; FIBROBLAST GROWTH FACTOR 21; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; RETINOL BINDING PROTEIN 4; ROSIGLITAZONE;

BLOOD GLUCOSE MONITORING; BODY FAT DISTRIBUTION; BODY MASS; CARDIOVASCULAR RISK; CATARACT; CHINESE; DIABETES CONTROL; DIABETES EDUCATION; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; EARLY DIAGNOSIS; EDITORIAL; FATTY LIVER; GENE MUTATION; GENETIC SUSCEPTIBILITY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HEALTH CARE COST; HEALTH EDUCATION; HUMAN; HYPERTENSION; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN TREATMENT; LATENT AUTOIMMUNE DIABETES IN ADULTS; LIFESTYLE; LIFESTYLE MODIFICATION; LIPID METABOLISM; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; QUALITY OF LIFE; WAIST CIRCUMFERENCE;

ANIMALS; CHINA; DIABETES MELLITUS; HUMANS;

EID: 73449098961     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.21.001     Document Type: Editorial

References (35)

1. Li LM, Rao KQ, Kong LZ, Yao CH, Xiang HD, Zhai FY, et al. A description on the Chinese National Nutrition and Health Survey in 2002. Chin J Epidemiol (Chin) 2005; 26: 478-484.
2. Pan CY. Status of diabetes control in China - the gap between guidelines and practice. Sect Endocrinol Foreign Med Sci (Chin) 2005; 25: 174-178.
3. Pan CY, Yang WY, Jia WP, Weng JP, Tian H. Management of Chinese patients with type 2 diabetes, 1998-2006: The Diabcare-China Surveys. Curr Med Res Opin 2009; 25: 39-45.
4. Bao YQ. Bulletin of the 12th National Diabetes Congress of Chinese Medical Association Diabetes Society. Chin J Endocrinol Metab (Chin) 2008; 24: 695-699.
5. Chen XB, Tang L, Chen HY, Zhao LY, Hu SL. Assessing the impact of complications on the costs of type 2 diabetes in urban China. Chin J Diabetes (Chin) 2003; 11: 238-241.
6. Zhang DM, Zhou ZG, Weng JP, Li LR, Deng H, Zhang C, et al. Etiological dissection in common anti-islet autoantibody -negative patients with type 1 diabetes. Natl Med J China (Chin) 2004; 84: 1247-1251.
7. Zhou ZG, Li X, Huang G, Peng J, Yang L, Yan X, et al. Rosiglitazone combined with insulin preserves islet β cell function in adult-onset latent autoimmune diabetes (LADA). Diabetes Metab Res Rev 2005; 21: 203-208.
8. Zhou ZG, Zhang C, Zhang DM, Huang G, Wang JP, Lin J. Clinical characteristics and diagnostic points of idiopathic type 1 diabetes and its subtypes. Chin J Diabetes (Chin) 2004; 12: 79-85.
9. Xiang KS, Wang YQ, Zheng TS, Jia WP, Li J, Chen L, et al. Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese diabetes. Diabetes 2004; 53: 228-234.
10. Xiang KS, Zheng TS, Jia WP, Wang YQ, Shen KX, Li J. The impact of polymorphism of calpain-10 gene on glucose intolerance status, insulin secretion and insulin sensitivity. Chin J Endocrinol Metab (Chin) 2001; 17: 290-294.
11. Wang CR, Hu C, Zhang R, Bao YQ, Ma XJ, Lu JY, et al. Common variants of hepatocyte nuclear factor 1β are associated with type 2 diabetes in a Chinese population diabetes. Diabetes 2009; 58: 1023-1027.
12. Hu C, Zhang R, Wang C, Ma X, Wang C, Fang Q, et al. A genetic variant of G6PC2 is associated with type 2 diabetes and fasting plasma glucose level in the Chinese population. Diabetologia 2009; 52: 451-456.
13. Hu C, Wang C, Zhang R, Ma X, Wang J, Lu J, et al. Variations in KCNQ1 are associated with type 2 diabetes and beta cell function in a Chinese population. Diabetologia 2009; 52: 1322-1325.
14. Xiang KS. Genetics studies of complex diseases-strategies and problems. Chin J Endocrinol Metab (Chin) 2000; 16: 1-2.
15. Chinese Diabetes Society. The recommendation of screen and diagnosis in diabetes mellitus with mitochondrial gene mutations. Natl Med J China (Chin) 2005; 85: 1951-1955.
16. Cai MY, Weng JP. The molecule etiology of persistent hyperinsulinemic hypoglycemia of infancy. Chin J Endocrinol Metab (Chin) 2006; 22: 401-404.
17. Pang C, Huang ZM, Zhu HL, Yu QQ, Yan JH, Liao ZH, et al. The study of Chinese type A insulin resistance family and insulin receptor gene mutation. Chin J Endocrinol Metab (Chin) 2005; 21: 237-239.
18. Yang WY. It is necessary to strengthen the exploration into the multiple organ damage caused by lipotoxicity. Natl Med J China (Chin) 2008; 88: 361-362.
19. Bai XP, Li HL, Yang WY, Xiao JZ, Wang B, Du RQ, et al. The mechanism of and relationship between lipid metabolism genes expression and insulin resistance in high fat-fed mice. Chin J Intern Med (Chin) 2007; 46: 751-754.
20. Yang WY. Insulin resistance as an early marker of non-alcoholic fatty liver. Chin J Intern Med (Chin) 2007; 46: 177-178.
21. Bai XP, Li HL, Yang WY, Xiao JZ, Wang B, Du RQ, et al. The sequence of fat deposit and its relationship with insulin resistance. Chin J Endocrinol Metab (Chin) 2007; 23: 307-310.
22. Du RQ, Li HL, Yang WY, Xiao JZ, Lou DJ, Wang B, et al. The expression of insulin signal transduction molecules and islet α cell insulin resistance. Natl Med J China (Chin) 2006; 86: 2542-2546.
23. Zhao WH, Xiao JZ, Yang WY, Wang Na, Wang X, Chen XP, et al. Relationship between hepatic insulin resistance and the expression of genes involved in hepatic glucose output. Chin J Hepatol (Chin) 2006; 14: 45-48.
24. Chinese Diabetes Society. The recommedations of the lower cut-off point of fasting blood glucose. Natl Med J China (Chin) 2005; 85: 1947-1950.
25. Metabolic Syndrome Coordination Group of Chinese Diabetes Society. Advice of metabolic syndrome from Chinese Diabetes Society. Chin J Diabetes (Chin) 2004; 12: 156-161.
26. Li GW, Zhang P, Wang JP, Yang WY, Gong QH, Li H, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008; 371: 1783-1189.
27. Yang WY, Lin LX, Qi JW, Yu ZQ, Pei HC, He GF, et al. The preventive effect of acarbose and metformin on the IGT population from becoming diabetes mellitus: a 3-year multicentral prospective study. Chin J Endocrinol Metab (Chin) 2001; 17: 131-134.
28. Li CL, Pan CY, Lu JM, Zhu Y, Wang JH, Deng XX, et al. Effect of metformin on patients with impaired glucose tolerance. Diabet Med 1999; 16: 477-481.
29. Weng JP, Li YB, Xu W, Shi LX, Zhang Q, Zhu DL, et al. Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet 2008; 71: 1753-1760.
30. Yang WY, Ji QH, Zhu DL, Yang JK, Chen LL, Liu ZM, et al. Biphasic insulin Aspart 30 three times daily is more effective than a twice daily regimen, without increasing hypoglycemia, in Chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs. Diabetes Care 2008; 31: 852-856.
31. Zhou J, Li H, Ran XW, Yang WY, Li Q, Peng YD, et al. Reference values for continuous glucose monitoring in Chinese subjects. Diabetes Care 2009; 32: 1188-1193.
32. Xiang KS, Jia WP, Lu JQ, Tang JL, Li J. Obesity in type 2 diabetes, its features and specificity. Natl Med J China (Chin) 2004; 84: 1768-1772.
33. Bao YQ, Lu JX, Wang C, Yang M, Li HT, Zhang XY, et al. Optimal waist circumference cutoffs for abdominal obesity in Chinese. Atherosclerosis 2008; 201: 378-384.
34. Jia WP, Wu HY, BaoYQ, Wang C, Lu JX, Zhu JH, et al. Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes. J Clin Endocrinol Metab 2007; 92: 3224-3229.
35. Li HT, Bao YQ, Xu AM, Pan XP, Lu JX, Wu HY, et al. Serum fibroblast growth factor 21 is associated with adverse lipid profiles and γ-glutamyltransferase but not insulin sensitivity in Chinese subjects. J Clin Endocrinol Metab 2009; 94: 2151-2156.